Trastuzumab Blocks the Receiver Function of HER2 Leading to the Population Shifts of HER2-Containing Homodimers and Heterodimers

HER2, a member of the Erythroblastosis Protein B/Human Epidermal Growth Factor Receptor (ErbB/HER) family of receptor tyrosine kinase, is overexpressed in 20~30% of human breast cancers. Trastuzumab, a HER2-targeted therapeutic monoclonal antibody, was developed to interfere with the homodimerizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jun, Mohan, Nishant, Nussinov, Ruth, Ma, Buyong, Wu, Wen Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931022/
https://www.ncbi.nlm.nih.gov/pubmed/33557368
http://dx.doi.org/10.3390/antib10010007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931022/
https://www.ncbi.nlm.nih.gov/pubmed/33557368
http://dx.doi.org/10.3390/antib10010007

Ejemplares similares